Skip to Main Content

Author Details

Cate Speake
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
2009
83
24
PMIDPaper TitleJournal TitlePublished Year
36227635Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis.J Clin Endocrinol Metab2023
37758901Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes.Commun Biol2023
37751304Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes.JCI Insight2023
37520758ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent.AACE Clin Case Rep2023
37794253Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.Nat Med2023
37886513Self-reactive germline-like TCR alpha chains shared between blood and pancreas.Res Sq2023
37940642A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes.Nat Commun2023
38096190Testing a new platform to screen disease-modifying therapy in type 1 diabetes.PLoS One2023
37572381OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.J Clin Endocrinol Metab2023
37406136Measuring anti-islet autoimmunity in mouse and human by profiling peripheral blood antigen-specific CD4 T cells.Sci Transl Med2023
37338983Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies.JCI Insight2023
37205332Mediators of monocyte chemotaxis and matrix remodeling are associated with the development of fibrosis in patients with COVID-19.medRxiv2023
37202589Approval of teplizumab: implications for patients.Nat Rev Endocrinol2023
37474341Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.J Clin Endocrinol Metab2023
36703975Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.Front Immunol2023
36894554SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.Nat Commun2023
36201618Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4+ T Cells in Type 1 Diabetes.Diabetes2023
35020411Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity.Sci Transl Med2022
35767821The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.PLoS Pathog2022
35388005Citrullination of glucokinase is linked to autoimmune diabetes.Nat Commun2022
36177823ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents.Pediatr Diabetes2022
36206464Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium.Pancreas2022
36206461Assessing the Pathophysiology of Hyperglycemia in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.Pancreas2022
36206462Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.Pancreas2022
36206460Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium.Pancreas2022
36098405Severe acute pancreatitis exhibits distinct cytokine signatures and trajectories in humans: a prospective observational study.Am J Physiol Gastrointest Liver Physiol2022
36282595IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function.JCI Insight2022
35288472Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.J Immunol2022
35313588The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.bioRxiv2022
35041021Characterising the age-dependent effects of risk factors on type 1 diabetes progression.Diabetologia2022
35025103Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes.Eur J Immunol2022
35022272Fewer LAG-3<sup>+</sup> T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.J Immunol2022
34342578Endomembrane targeting of human OAS1 p46 augments antiviral activity.Elife2021
33881515Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count.Endocr Rev2021
33483981The many faces of islet antigen-specific CD8 T cells: clues to clinical outcome in type 1 diabetes.Immunol Cell Biol2021
33917702Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19.J Clin Med2021
33662335Combination therapy in recent-onset type 1 diabetes.Lancet Diabetes Endocrinol2021
34806648Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes.JCI Insight2021
31557315In-vivo assessment of T cell kinetics in individuals at risk for type 1 diabetes.Clin Exp Immunol2020
31815738Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.J Clin Invest2020
31907557Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates.Diabetologia2020
32019856Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals.Diabetes Care2020
31826866Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis.Diabetes2020
31913467Circulating Unmethylated Insulin DNA As a Biomarker of Human Beta Cell Death: A Multi-laboratory Assay Comparison.J Clin Endocrinol Metab2020
33186361Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.PLoS One2020
32573495Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells.JCI Insight2020
32669415Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals. Diabetes Care 2020;43:913-917.Diabetes Care2020
32231298Beta cell-specific CD8<sup>+</sup> T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes.Nat Immunol2020
32291282Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01.Diabetes2020
30530850Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes.Diabetes Care2019
  • 1 - 50 of 83

Recommended Authors

University of Florida
Career Start Year 2017
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 2015
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 2012
Number of shared co-authors 1
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
J. David Gladstone Institutesgrid.249878.8
Career Start Year 2011
Number of shared co-authors 1
University of North Carolina School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Sorbonne University INSERM
Career Start Year 2010
Number of shared co-authors 1
The University of Queensland
Career Start Year 2008
Number of shared co-authors 0
University of California san francisco
Career Start Year 2006
Number of shared co-authors 13
Translational and Clinical Data Sciences
Career Start Year 2006
Number of shared co-authors 0
University of Miami Miller School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Universite Paris Saclay
Career Start Year 2002
Number of shared co-authors 0
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 5
South Australian Health and Medical Research Institute
Career Start Year 2002
Number of shared co-authors 0
Yale School of Medicine, Yale University
Career Start Year 2002
Number of shared co-authors 4
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
University of California
Career Start Year 1999
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 3
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1996
Number of shared co-authors 0
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
University of Florida College of Medicine
Career Start Year 1989
Number of shared co-authors 6
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
Universidad Cardenal Herrera-CEU, CEU Universities
Career Start Year 1989
Number of shared co-authors 1
Monash Biomedicine Discovery Institute, Monash University
Career Start Year 1989
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 7
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1985
Number of shared co-authors 2
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 1
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 1

Collaborators

Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 41
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 11
8Benaroya Research Institute
Co-authored papers 11
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 11
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 10
Wash Benaroya Research Institute at Virginia Mason
Co-authored papers 10
Center for Translational Immunology
Co-authored papers 9
Center for Systems Immunology, Benaroya Research Institute
Co-authored papers 8
Co-authored papers 7
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 6
Center for Systems Immunology, Benaroya Research Institute Seattle
Co-authored papers 6
The Henry Jackson Foundation.
Co-authored papers 5
Yale University
Co-authored papers 5
College of Medicine, Diabetes Institute, University of Florida
Co-authored papers 4
Benaroya Research Institute at Virginia Mason
Co-authored papers 4
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 4
Benaroya Research Institute
Co-authored papers 3
Co-authored papers 3
The Ohio State University, Wexner Medical Center
Co-authored papers 3
University of Pittsburgh Medical Center
Co-authored papers 3
Co-authored papers 3
Center for Systems Immunology, Benaroya Research Institute
Co-authored papers 3
Center for Translational Immunology
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Fred Hutchinson Cancer Center
Co-authored papers 2
Co-authored papers 2
Benaroya Research Institute at Virginia Mason
Co-authored papers 2
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Benaroya Research Institute at Virginia Mason
Co-authored papers 2